Clinical Trial Update: Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis

View source ↗

Summary

This trial update evaluates the effect of Nebido (testosterone undecanoate) on bone mineral density in hypogonadal paraplegic patients with osteoporosis. It rep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism
• Osteoporosis
• Paraplegia

Drugs mentioned

• Nebido (testosterone undecanoate)

Snippet

Sponsor: Bayer | Conditions: Hypogonadism, Paraplegia | Status: COMPLETED